INTRODUCTION
Gene expressioni sr egulated at multiple steps,r anging fromt ranscription initiationt op ost-translational modification and/ord egradation. Recently, small RNA-mediated gene-silencing phenomena in eukaryotes (Zamore and Haley 2005) have been extensively investigated due to their important regulatory roles in diverse organisms. The genesilencing mechanism involves trans-acting small RNAs such as small interfering RNAs (siRNAs) and microRNAs (miRNAs) as essential regulatory RNA elements. siRNAsare key molecules in the RNAinterference (RNAi) pathway, in which long double-stranded RNAs (dsRNAs) or short hairpin RNAs (shRNAs) are processed by the RNase III enzyme Dicer, and the resulting siRNAs of~21 nt in length function as guides for specific mRNA degradation in the RNA-induced silencing complex (RISC)( for reviews, see Mello and Conte2 004) .
Thediscovery of RNAi added anotherlayer of functionality of RNAmolecules to thealreadyversatile repertoire of biological functions. Furthermore, theu niversal nature of RNAi mechanism suggested itse normousp otential as at oolt oc ontrolg enee xpressioni nc ulturedc ells and organisms.I nf act, RNAi is noww idely useda sasimple ande ffective methodt ok nock down gene expression in diverse organisms. Furthermore, therapeutica pplications of siRNAs areb eing explored( forr eview, see Hannona nd Rossi 2004) .
In thisr eport we describe an ovels trategyf or artificial gener egulationi nm ammalian cells using RNAi as ab asal system.Inthisapproach, RNAi is specifically modulated by theophylline thorough the binding to its aptamer. Aptamers are RNA or DNA oligonucleotides that can bind specific ligands with high affinity and specificity (Ellington and Szostak 1990; Tuerk and Gold 1990) , and they have been used fora rtificial gene regulation in vivo (Werstuck and Green 1998; Harvey et al. 2002; H anson et al. 2003; Suesse ta l. 2003; B uskirk et al. 2004; Desai and Gallivan 2004; B ayer and Smolke 2005) . Our new approacht o controlling gene expression in mammalian cells combines the versatility of siRNAs to target arbitrary genes andt he powerful in vitro selection technology to develop RNA aptamers for av ariety of molecules.
RESULTS AND DISCUSSION
RNAii nduction with aptamer-fused shRNAs andi ts inhibition by theophylline
We constructed ah uman U6 promoter-driven vector that transcribes an shRNA in which the in vitro-selected RNA aptamer for theophylline (Jenison et al. 1994; Z immermannetal. 1997) isfused to the loop region of the shRNA with a1 9-bp double-stranded stem targeting the enhanced green fluorescent protein (EGFP) gene (pE19T) ( Fig. 1A) . When this construct was cotransfected into HEK293 cells with pEGFP-N1 and pDsRed1-N1 (EGFP and DsRed expression vector, respectively), EGFP silencing was inhibited in ad ose-dependentm anner to the theophylline concentration ( Fig. 1B) . DsRedf luorescence was used to normalize for transfection efficiency. The corresponding shRNAe xpression vector that lacks the aptamer (pE19) (Fig.1 A) retained its RNAi activity up to 1m Mt heophylline with small increasesi nE GFP expressiona t5and 10 mM. The cells grew slightly slower at higher concentrations of theophylline (5 and 10 mM),w hich may account for the minori ncrease in EGFP expression, possibly due to nonspecific pleiotropic effects. Addition of up to 1m Mc affeine, which is structurally similar to theophylline butd oesn ot bind to the aptamer ( Jenison et al. 1994) , did not affect RNAi efficiency (data not shown), and higher concentrations of caffeine proved to be toxic to the cultured cells (data not shown).
Similar RNAi inhibition by theophylline was obtained when DsRedgenewas targeted instead of EGFP (Fig. 2) .The results are consistentwith the modulardesign of theaptamerfuseds hRNAs comprised of ag ene-targeting stem anda molecular-sensinga ptamer that functioni ndependently.
Two related constructs (pE20Ta nd pE21T) (Fig. 1A ) were examined to probe the operating mechanism of the system.p E20T and pE21T transcripts contain 20 and 21 double-stranded bp in the stem region, respectively. Both constructs retained gene-silencing activity but did not appreciablyrespond to theophylline (Fig.1 C) .The expected Dicer cleavage siteso fp E20T and pE21T transcripts lie outside of the theophylline-binding site within the aptamer (Fig. 1A) , consistent with their lack of response FIGURE 1. Design of aptamer-fusedshRNAs andeffect of theophylline on RNAi inducedbythe shRNAs. ( A )Secondary structures of putative transcripts from pE19,pE19T, pE20T,a nd pE21T.Boxed nucleotidesindicatethe anti-sense strandtargetingE GFP, grayn ucleotidesi ndicate the loop sequencef rom the pSilencer vector( Ambion) (Brummelkamp et al. 2002) ,c ircled nucleotidesi ndicate bases that interactw ith theophylline (Zimmermann et al.1 997) ,a nd arrowheadsi ndicate putativeD icer cleavage sites. RNAp olymerase III transcriptsa re knownt o have heterogenous39 terminus with one to four Uresidues (Bogenhagenand Brown1981; Miyagishiand Taira 2002) . Forsimplicity, structures with twoUresidues are depicted.I ts houldb en otedt hat thep E19 transcript( E19s hRNA)w as predicted to havea21-bp stem region consisting of a1 9-bp stem encodinga nE GFPs equencea nd an additional2 -bps temf romt he loop sequence recommendedb yt he manufacturer. ( B )D ose-dependenti nhibition of RNAi with pE19Tb yt heophylline. HEK293 cellsw erec otransfected with pEGFP-N1a nd pDsRed1-N1,and pE19(withoutaptamer)orpE19T(with aptamer) in a96-well microplate.Fluorescencemeasurements were performed 48 h aftertransfection, andthe ratios of EGFP andDsRed fluorescenceintensity were calculated.The ratios were then normalized to those from cells transfected with an shRNA expression vector with as crambleds equencethat has no significanthomologyw itht he humangenome. The data are averageso ft riplicate transfectionsa nd errorb arsr epresent standard deviations.( C )E ffect of shRNA stem length on theophyllinedependentR NAi inhibition. HEK293 cellsw erec otransfectedw ithp EGFP-N1, pDsRed1-N1,a nd either pE19, pE19T,p E20T,o rp E21T in a9 6-well microplate. (Fig.1 C) . These results suggested that theophylline binding to the aptamero fp E19Tt ranscript interferes with Dicer cleavage due to the proximity of the binding pocket to the putative Dicer cleavage site (Fig. 1A) .
Inhibition of Dicer-mediated shRNA cleavage by theophylline in vitro
To test the possibility of Dicer-mediated cleavage of pE19T transcript being inhibited by theophylline, we prepared the predictedRNA transcripts of pE19 and pE19T (Fig. 1A ) by in vitro transcription (E19 and E19T, respectively) and reactedt hem with recombinant Dicer in the absence and the presence of theophylline. As we expected, dosedependent inhibition of Dicer-mediated siRNA production wasobserved for E19T but not for E19 (Fig. 3) , supporting the proposed mechanism. The same reaction using E20T (Fig. 1A ) also resulted in dose-dependent inhibition of Dicer cleavage by theophylline, but the degreeofinhibition was smallert han that of E19T. These observations indicate that the proximity of Dicer cleavage site to the theophylline-binding site is important in modulatingDicer activity.
In addition to siRNA, longer cleavage products were detected in the Dicer cleavage reactions of E19T and E20T (indicated by an asterisk in Fig.3 ). Judgingfrom their sizes (between 30 and 50 nt; data not shown) and their detectabilityw ith the EGFP sense sequencep robe,t hey are expectedt ob ep artial cleavage products between the 21st and 22nd nucleotides from the 5 9 end of the shRNAs (a 44-nt fragmentf romE 19T and a4 6-ntf ragment from E20T) (Fig. 1A) . This observation suggests that insertion of theophylline aptamer decreased the efficiencyo fs imultaneous cleavage of both strands by an intramolecular heterodimer of the twoRNaseIII domains of Dicer (Zhang et al. 2004; M acrae et al.2 006) , presumably due to the relatively large size of the aptamer and its unstructured nature in the absence of theophylline (Zimmermanne ta l. 1997). Addition of theophylline also resulted in reduction of the longer species, which was more evident with E20T than E19T (Fig. 3) , suggesting that cleavage between A21 and U22 in E20T (cf. Fig. 1A ) is more susceptible to theophylline binding than that between U21 and A22 in E19T (cf. Fig. 1A ). These longer products were also observed in vivo( see below). Siolas et al. (2005) r ecently reported that their shRNA with a1 9-bp stem and a4 -bpl oopw as not cleaved by recombinant Dicer in vitro butw as still able to induce RNAi in vivo. In contrast,o ur shRNA with a1 9-bp stem 3. Inhibition of Dicer-mediated shRNA cleavage by theophylline. In vitro transcribed E19, E19T, and E20T shRNAs were incubated with recombinant Dicer in the presence or the absence of theophylline. Reaction products were separated on a1 5% denaturing polyacrylamide gel, and detected by Northern blotting using a59 -biotinylated DNA oligonucleotide probe encoding an EGFP sense sequence. The asterisk indicates the position of partially cleaved shRNAs (putative). The sizes of shRNA precursors (49 nt for E19, 65 nt for E19T, 67 nt for E20T) and their diced products (siRNA, 21 nt) were verified using dsRNA Ladder (New England Biolabs) and SYBR Gold Nucleic Acid Gel Stain (Molecular Probes) (data not shown).
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Inhibition of siRNA production by theophylline in vivo
To investigate the effects of theophylline on siRNA accumulation in vivo, Northern analysis was performedu sing small RNAs isolated from HEK293 cells, which were cotransfected with pEGFP-N1, pDsRed1-N1, and oneo f the shRNA expressionp lasmids( pE19,p E19T, pE20T, or pE21T) and incubated in the presence or the absence of 10 mM theophylline. Strongb ands corresponding to the unprocessed shRNAs were detected in all cell extracts regardless of theophylline addition (Fig. 4B) . As evident fromt he bottomp icture of Figure 4B , siRNA generation fromE 19T shRNA was almost completely inhibited by theophylline, whereas those from E20T and E21T were diminished but still detectable.N os ignificantd ifference in the siRNAl evels of pE19-transfected cells in response to theophylline was observed. These observations were consistent with the result of fluorescence measuremento ft he same samples (Fig. 4A) as well as the in vitro Dicer cleavage results (Fig.3 ) .
The putative partially cleaved RNA specieso bserved in vitro were also detected in vivo (indicated by an asterisk in Fig. 4B ). Additionally, RNA species of~30 nt were also detected fromthe cell lysatestransfected with the aptamerfuseds hRNA expressionv ectors (indicated by an arrow in Fig. 4B ). The intensity of these bands was also diminished in responset ot heophylline, suggesting that the cleavage site(s) responsible for thesespecies is locatedwithin or near the theophylline-binding pocket. Although the exact nature of theseb y-products awaits further investigation, the similar levels of the RNA speciesd etected in pE19T,p E20T, or pE21T-transfected cells in the presenceoftheophylline and the difference in observed RNAi among thesec ells suggest that these RNA species aren ot involved in the silencing of EGFP.
Taken together, theophylline clearly inhibitss iRNA production froma ptamer-fused shRNAsi nv itro and in vivo, but the highest degree of inhibition is observedwith E19T, in which one of the putative Dicer cleavage sites overlaps with the theophylline-binding site (Fig. 1A) . Consequently, theophylline-induced RNAi inhibition in vivo was only observed in cells transfected with theaptamer-fused shRNA expression vectors with a1 9-bp stem (pE19T and pD19T) (Figs.1 ,2 ) . et al. (2005) r ecently reportedt wo ATP analogs that inhibit RNAi in mammalian cells discovered by screening of ac hemical library.T hese moleculesa re likely to inhibit ac ellular factor involved in the early RNAi pathway to induceg eneral RNAi inhibition, whereas our system was designed to effect specific control of RNAi by as mall molecule directly interactingwith an shRNA.Toour knowledge, our system is the first demonstration of sequencespecific RNAi inhibition by as mall molecule at ad efined mechanistic step.
Comparison with other RNAi regulation methods

Chiu
Anti-miRNA oligonucleotides (AMOs) have been used to inhibit specific miRNAsand siRNAs in vivo(for review, see Weiler et al. 2005) . AMOs are easy to design and can inhibit both endogenous miRNAs and synthetic siRNAs. However, the exact process in which AMOs exertt heir function in the RNAi pathway is not clear. Deliverya nd removal of AMOs are also more complicated than many smallmolecule drugs, which may be more advantageous for experiments requiring temporal control.
The most popular technique for achieving temporal control of RNAi in cultured cells is probably the use of inducibleshRNA vectorsbased on therobusttetracyclineor ecdysone-inducible systemsu sing engineered transcription HEK293 cells were cotransfected with pEGFP-N1 and pDsRed1-N1, and either pE19, pE19T, pE20T, or pE21Tin6-well plates. Small RNA species were isolated from the transfected cells after measuring EGFP/DsRed fluorescence. ( A )N ormalized fluorescence data of the transfected cells used to isolate small RNA species (cf. Fig. 1C). ( B )N orthern blotting of small RNAs from transfected cells. Expression of U6 snRNA was used as al oading control. In vitro-diced products of E19 and E19T in the presence of theophylline (cf. Fig. 3 ) were used as size markers. The asterisk indicates the position of partially cleaved shRNAs (putative), and the arrow indicates the position of unidentified cleavage products specifically observed in vivo (see text for details). Sandy et al. 2005) . While these inducible systems offer various features needed for many applications,t he aptamer-fused shRNA regulatory strategyo perating at the Dicer cleavage step may be used in combination with the existing inducible shRNA expression systemst o achievem ore complex or improved regulation of RNAi in engineered cells. The ability to control RNAi at the Dicer cleavage step may result in afaster response compared with transcriptional control. Moreover, the modularity of the aptamer and the gene-targeting stem opens the possibility to regulate genee xpression in responset oe ndogenous metabolites or proteinsf or which RNAa ptamers are selected in vitro. Reversibility of the RNA silencing effect will need to be demonstrated using stable transfectants of the aptamer-fused shRNA expressioncassette, which will be the subject of future investigation.
pE19Ta nd pD19T transcripts can be classified as RNA genetic switches that allow regulationo fe xogenous genes without exogenous protein factors. To our knowledge, only twosuch genetic switches that functioninmammalian cells haveb een reported.W erstuck and Green (1998) inserted H33342 dye aptamers in the 5 9 -untranslated region( UTR) of ar eporter transcript whose translation was negatively regulated in the presence of the cognate ligand. Yen et al. (2004) recently reported asystem in which aribozyme integratedi n5 9 UTR of ar eporter mRNAw hose self-cleavage wasi nhibited by small molecule ribozyme inhibitors.
Althoughn ot directly demonstrated in this work, the modularity of our system provides au nique potential of regulating endogenous genes not possible with the previously described systems ( Werstuck and Green 1998; Yen et al. 2004) . RNA genetic switches have some advantages over those based on engineered protein transcription factors such as reduced risk of immunogenic complications and smallerg enetic sizes that may be beneficial fori nv ivo applications. In light of the recentp rogress in natural and artificialRNA-based generegulatory mechanisms in bacteria (Isaacsetal. 2004; Davidson and Ellington 2005) and yeast (Suesse ta l. 2003; Buskirk et al. 2004; Bayer and Smolke 2005) , small molecule-regulatedR NA genetic switches in mammalian cells should further advance our understanding of the roleso fR NA in gene regulationa sw ell as their applications.
MATERIALS AND METHODS
Plasmid construction
pEGFP-N1 and pDsRed1-N1 were obtained from Clontech. pSilencer 2.1-U6 hygro (Ambion) was used for constructing all RNAi vectors. pE19 (E19 stands for 19 bp of shRNA encoding an EGFP target sequence ), pE19T (T stands for theophylline aptamer inserted in the loop region of shRNA), pD19 (D stands for DsRed), and pD19T were produced by ligating phosphorylated and annealed oligonucleotides with pSilencer 2.1-U6 hygro. Oligonucleotides used were as follows (a pair of annealed oligonucleotides was indicated by ''&''): pE19: 5 9 -GATCCGGCAAGCTGACCCTGAAGT&5 9 -TCTCTTG AAACTTCAGGGTCAGCTTGCCG, and59 -TTCAAGAGAACT TCAGGGTCAGCTTGCCTTTTTTGGAAA &59 -AGCTTTTCC AAAAAAGGCAAGCTGACCCTGAAGT; pE19T: 5 9 -GATCCGGCAAGCTGACCCTGAAGT &5 9 -GGTATA CTTCAGGGTCAGCTTGCCG, and 5 9 -ATACCAGCCGAAAG GCCCTT &59 -CTGCCAAGGGCCTTTCGGCT, and 5 9 -GGCA GACTTCAGGGTCAGCTTGCCTTTTTTGGAAA &59 -AGCTT TTCCAAAAAAGGCAAGCTGACCCTGAAGT; pD19: 5 9 -GATCCAGCGCGTGATGAACTTCGA &5 9 -AGTTCAT CACGCGCTG, and 5 9 -TTCAAGAGATCGAAG &5 9 -TGAACT TCGATCTCTTGAATCGA, and 5 9 -TTCATCACGCGCTTTTT TGGA &5 9 -AGCTTCCAAAAAAGCGCGTGA; and pD19T: 5 9 -GATCCAGCGCGTGATGAACTTCGA &5 9 -AGTTCA TCACGCGCTG,a nd 5 9 -ATACCAGCCGAAAGGCCCTTGGCA GTCGAAG &5 9 -TGAACTTCGACTGCCAAGGGCCTTTCGG CTGGTATTCGA, and 5 9 -TTCATCACGCGCTTTTTTGGA & 5 9 -AGCTTCCAAAAAAGCGCGTGA.
At arget sequence of the DsRed1 gene (59 -AGCGCGTGATG AACTTCGA) was chosen according to the criteria established by Reynolds et al. (2004) . pE20T and pE21T were constructed from pE19B, which was engineered to contain two BbsI sites in the loop region of pE19. pE19B was produced by ligating phosphorylated and annealed oligonucleotides of the following sequences with pSilencer 2.1-U6 hygro: 5 9 -GATCCGGCGAGCTGACTCTGAAGTATGTCTTCTTT TTTCTCGAGA &5 9 -GAGAAAAAAGAAGACATACTTCAGAGT CAGCTCGCCG, and5 9 -CTTGAAGACTAACTTCAGGGTCAGC TTGCCTTTTTTGGA &5 9 -AGCTTCCAAAAAAGGCAAGCTGA CCCTGAAGTTAGTCTTCAAGTCTC.P hosphorylateda nd annealed oligonucleotidesofthe following sequenceswereligated to theB bsI-digested pE19B to produce pE20T andp E21T.O ligonucleotides used to construct pE20T were 5 9 -AAGTTATAC CAGCCGAAAGGCCCTTGGCAGA &5 9 -AAGTTCTGCCAAGG GCCTTTCGGCTGGTATA. Oligonucleotides used to construct pE21T were 5 9 -AAGTTTATACCAGCCGAAAGGCCCTTGGCAG GA &5 9 -AAGTTCCTGCCAAGGGCCTTTCGGCTGGTATAA.
Cell culture andt ransfection HEK293 cells were maintained in a5%CO 2 -humidified incubator at 37°Ci nD ulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Invitrogen), 100 U/mL penicillin, and 100 m g/mL streptomycin (Invitrogen). One day before transfection, HEK293 cells were trypsinized and diluted 1:5 with fresh medium, and transferred to 96-well plates (130 m L/well). Cotransfection of pEGFP-N1, pDsRed1-N1, and an RNAi vector was carried out using PolyFect (QIAGEN) according to themanufacturer's instructions with modifications. Specifically, 10 ng of pEGFP-N1, 20 ng of pDsRed1-N1, and 100 ng of an RNAi vector were used with 2 m Lo fP olyFect reagent per well. Cells were incubated in a5 %C O 2 -humidified incubator at 37°Cinthe HEK293 medium supplemented with the indicated concentrations of theophylline or caffeine for 48 hb efore fluorescence measurements.
714
RNA, Vol. 12, No. 5
Fluorescence measurements
To quantitatively determine in vivo RNAi activity, dual fluorescence reporter systems using EGFP and DsRed (RFP) have been developed and used by many researchers Rana 2002, 2003; Chiu et al. 2004 Chiu et al. , 2005 Shah et al. 2005; Yang et al. 2005) . Our assay procedure was established according to the previous reports with some modifications. EGFP and DsRed fluorescence were detected with Safire 2 microplate reader (Tecan) according to the manufacturer's instructions. Before measuring fluorescence intensity, medium was removed from each well, and 150 m Lo f prewarmed (37°C) phosphate-buffered saline (PBS) was added and incubated at 37°Cfor 10 min in the instrument. Measurement conditions were as follows: measurement mode, fluorescence bottom well reading; excitation wavelength, 484 nm (for EGFP) or 558 nm (for DsRed); emission wavelength, 510 nm (for EGFP) or 583 nm (for DsRed); excitation bandwidth, 5n m; emission bandwidth, 5n m; gain, optimal; number of reads, five; temperature, 37°C. Data were processed as follows: First, fluorescence values of EGFP were divided by those of DsRed to obtain EGFP/ DsRed (DsRed fluorescence was used to normalize for transfection efficiency), and the average values and standard deviations of EGFP/DsRed from triplicate samples were calculated. Next, the average values and the standard deviations were normalized to those from cells transfected with an shRNA expression vector that has as crambled sequence with no significant homology with the human genome (Ambion, p Silencer 2.1-U6 hygro Negative Control, which expresses an shRNA with the following sequence: 5 9 -ACUACCGUUGUUAUAGGUGUUCAAGAGA CACCUAUAA CAACGGUAGUU-3 9 ;d ouble-stranded stem underlined)t oo btain ''NormalizedE GFP/DsRed'' values (for DsRed-targeting experiments, normalized DsRed/EGFP values were obtained). Fluorescence values at least1 0t imes higher than thosef rom mock-transfected sampleswereusedfor calculations.Wedid not subtract autofluorescence values of mock-transfected samples from thoseo fp lasmid-transfected samples, becausea utofluorescence values from mock-transfecteds amplesw ere usually <10% of those from plasmid-transfected samples, and the effect of the autofluorescence subtraction was negligible.
In vitro processing of shRNAs by recombinant Dicer E19, E19T, and E20T shRNAs were prepared by in vitro transcription using AmpliScribe T7 High Yield Transcription Kit (Epicentre). Template DNAs were prepared by annealing and T4 DNA polymerase-mediated extension of synthetic oligonucleotides. Oligonucleotides used to generate an E19 template were 5 9 -GCGTAATACGACTCACTATAGGCAAGCTGACCCTGAAGT TTCAAGAGAAC &5 9 -AAGGCAAGCTGACCCTGAAGTTCTCT TGAAAC (underline indicates T7 promoter sequence). Oligonucleotides used to generate an E19T template were 5 9 -GCGTAATA CGACTCACTATAGGCAAGCTGACCCTGAAGTATACCAGCCG AAAG &5 9 -AAGGCAAGCTGACCCTGAAGTCTGCCAAGGG CCTTTCGGCTGGTATAC (underline indicates T7 promoter sequence). Oligonucleotides used to generate an E20T template were 5 9 -GCGTAATACGACTCACTATAGGCGAGCTGACTCTGAA GTTATACCAGCCGAAAG &59 -AAGGCAAGCTGACCCTGAAG TTCTGCCAAGGGCCTTTCGGCTGGTATAAC (underline indicates T7 promoter sequence). In vitro-transcribed shRNAs were purified with a15% polyacrylamide/7 Murea denaturing gel prior to use.
shRNA (12 pmol) was mixed with 0.75 units of recombinant Dicer enzyme (Stratagene) in 10 m Lo fr eaction mixture containing 27.5 mM Tris-HCl (pH 8.0), 225 mM NaCl, 2.5 mM MgCl 2 , and 0, 0.1, 1, or 10 mM theophylline, and incubated at 37°Cfor 18 h.
Isolation of small RNAs from transfected cells
At otal of 150 ng of pEGFP-N1, 300n go fp DsRed1-N1, and 1.5 m go fa nR NAi vector were cotransfected into HEK293c ells using20 m LofPolyFect reagent (QIAGEN) in 6-well plates. Cells were incubated in a5 %C O 2 -humidifiedi ncubator at 37°Ci n theH EK293 medium supplementedw ith 0o r1 0m Mt heophylline for 47 h. Afterm easurement of fluorescence intensity as describeda bove, small RNAs were isolated using mirVana miRNA Isolation Kit (Ambion) accordingtothe manufacturer's instructions.
Northern blotting
A0.5-m Laliquot of in vitro reaction products (0.6 pmol RNA; see above) or 1 m go fs mall RNAs from transfected cells (see above) was separated on a1 5% polyacrylamide/7 Mu rea denaturing gel using NorthernMax Formaldehyde Load Dye (Ambion) and electroblotted to BrightStar-Plus Positively Charged Nylon Membrane (Ambion). After prehybridization in ULTRAhybOligo Hybridization Buffer (Ambion) at 25°Cf or 30 min, blots were incubatedwitha5 9 -biotin-labeledDNA oligonucleotideprobe (100 ng/mL) for EGFP (59 -AAAAAGGCAAGCTGACCCTGAAGT; underline corresponds to the plus strand of shRNAs) (cf. Fig. 1A ) in the same buffer at 25°Co vernight. For small RNA analysis of transfected cells, aprobe for U6 small nuclear (sn) RNA (59 -AAA ATATGGAACGCTTCACGAATT) was also added (100 ng/mL). Blots were washed three times (once at 25°Cf or 5m in, once at 42°Cf or 5m in, once at 42°Cf or 15 min) using al ow-stringency buffer (23 SSC, 0.1% SDS), and hybridized probes were detected using BrightStar BioDetect Kit (Ambion) according to the manufacturer's instructions. Chemiluminescence detection was performed using IVIS Imaging System (Xenogen).
